CMN-006(CoImmune)

Recently, the improvement of gelatin-based films for usage in food packaging has attracted more attention owing to their non-toxicity, biodegradability, availability, and renewability. In the current study, the improved gelatin-based films were produced using covalent interaction through dialdehyde kappa-carrageenan (DAK-car) and thymol-loaded zein nanoparticle content. The influences of DAK-car into the matrix of gelatin films (GEL) on the structural, total soluble matter (TSM), moisture content (MC), and water vapor permeability (WVP), and mechanical properties were investigated. After the formation of covalent crosslinking amongst the amino groups of GEL and the dialdehyde groups of DAK-car with the blending ratio of 1:2 (GEL 4% w/v): (DAK-car 1% w/v), a remarkably (p < 0.05) reduction was saw in TSM, MC, and WVP of film. The tensile strength of this film (72.26 ± 0.3 MPa) was ~20-fold higher compared with pure GEL film. It should also be noted that the presence of zein nanoparticles (ZNPs) did not have a notably effect on improving the attributes of gelatin-based film. However, the presence of thymol in concentrations of 0.25 and 0.5 mg/mL showed acceptable antioxidant and antimicrobial activities. As a result, GEL/DAK-car with blending ratio of 1:2 containing thymol-loaded ZNPs films demonstrated the valuable potential for application in active food packaging.

We describe a method of rendering polyclonal cytokine-induced killer cells (CIK) specific against cytomegalovirus (CMV), focusing on GMP compliance. Peripheral blood mononuclear cells (PBMNC) are stimulated with pooled CMV peptides pp65 and IE-1 for 16-24 h and the reactive T cell subset which up-regulate CD137 is further co-stimulated with anti-CD137, followed by expansion in G-Rex flasks under standard CIK culture condition. This method generates a large number CMV-specific CIK with superior potency compared to published method currently in clinical trials. The cytotoxicity as measured by chromium release assay correlates with the upregulation of CD107a upon peptide re-challenge as measured by flow cytometry. CMV-CIK at maturity consist of mainly late effector memory CD8 T cells and have a skewed TCR repertoire with preferential expansion of a few families. Such CMV-CIK retain their function after freezing and thawing. CMV-CIK thus generated is ready for clinical trial against drug-resistant CMV disease.